LEUKEMIA & RELATED MALIGNANCIES
Chronic Lymphocytic Leukemia
Poster: CLL-140 Booster and BTKi Interruption Improve Response to SARS-CoV-2 Vaccine in Patients With CLL

https://doi.org/10.1016/S2152-2650(22)00854-0Get rights and content

Cited by (0)

View Abstract